NCT05766475

Brief Summary

The goal of this clinical trial is to test whether an established preventive intervention (group interpersonal therapy) delivered virtually shows the same benefits for preventing postpartum depression as it does when delivered in person.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
900

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Mar 2023Jun 2027

First Submitted

Initial submission to the registry

March 1, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 13, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

March 13, 2023

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

May 17, 2023

Status Verified

May 1, 2023

Enrollment Period

4.2 years

First QC Date

March 1, 2023

Last Update Submit

May 15, 2023

Conditions

Keywords

Prenatal depressionhealth disparitiespreventative interventionvirtual therapyinterpersonal therapy

Outcome Measures

Primary Outcomes (8)

  • Symptom Checklist 20 (SCL 20)

    Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

    6 weeks after birth

  • Symptom Checklist 20 (SCL 20)

    Self reported depression scores.Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

    3 months after birth

  • Symptom Checklist 20 (SCL 20)

    Self reported depression scores

    6 months after birth

  • Symptom Checklist 20 (SCL 20)

    Self reported depression scores. Possible range of scores is 0 to 80, with the higher scores indicating higher depression levels.

    12 months after birth

  • Center for Epidemiologic Studies Depression Scale (CES-D)

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

    6 weeks after birth

  • Center for Epidemiologic Studies Depression Scale (CES-D)

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

    3 months after birth

  • Center for Epidemiologic Studies Depression Scale (CES-D)

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

    6 months after birth

  • Center for Epidemiologic Studies Depression Scale (CES-D)

    Self reported depression scores. Possible range of scores is 0 to 60, with the higher scores indicating higher depression levels.

    12 months after birth

Study Arms (2)

In-Person Delivery of Group Preventative Intervention (ROSE)

ACTIVE COMPARATOR

The Reach Out, Stay Strong, Essentials for New Mothers Program (ROSE), is an established Interpersonal Therapy (IPT)-oriented group intervention for postpartum depression. ROSE is a brief (5-session) program and its content addresses social support, role transition to motherhood, communication skills, and psychoeducation on PPD. ROSE consists of four 90-minute, weekly in person group sessions and one individual booster session. The first four sessions of ROSE will be delivered in groups of 6 to 20, and conducted in both English and Spanish. For the in-person groups, transportation via Uber will be provided to Denver Health Medical Center to reduce barriers to attendance.

Behavioral: ROSE Program: In Person

Virtual Delivery of Group Preventative Intervention (ROSE)

EXPERIMENTAL

In parallel to ROSE delivered in person, virtual ROSE consists of four 90-minute, weekly group sessions conducted via Zoom and one individual booster session.

Behavioral: ROSE Program: Virtual

Interventions

In-person preventative intervention for postpartum depression that includes content on building social support and communication skills in relationships, navigating the role transition to motherhood, and learning about signs and symptoms of depression after delivery.

Also known as: Rose, Group IPT, La Luz
In-Person Delivery of Group Preventative Intervention (ROSE)

Virtual ROSE covers the same content (e.g. improving social support and communication) and is delivered by the same facilitators as the in-person intervention via telehealth.

Virtual Delivery of Group Preventative Intervention (ROSE)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English or Spanish speaking
  • Less than 30 gestational weeks

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Denver Health Medical Center

Denver, Colorado, 80204, United States

RECRUITING

Related Publications (1)

  • Liu DY, Perry NS, Demers CH, Hyer JS, Alamo A, Vuksanovich P, Dube N, Flanagan ER, Gallop RJ, Rhoades GK, Davis EP. Virtual versus in-person ROSE program (La Luz) as universal prevention for perinatal depression: Protocol for a randomized controlled trial in a safety net hospital. Contemp Clin Trials. 2025 Aug;155:107988. doi: 10.1016/j.cct.2025.107988. Epub 2025 Jun 15.

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Galena Rhoades, PhD

    University of Denver

    PRINCIPAL INVESTIGATOR
  • Elysia P Davis, PhD

    University of Denver

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Galena Rhoades, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2023

First Posted

March 13, 2023

Study Start

March 13, 2023

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

May 17, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

All data will be shared in accordance with NIMH Data Archive requirements.

Locations